BlueRock Therapeutics Stock

bluerocktx.comBioTechFounded: 2016Funding to Date: $225MM

BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases with a platform that harnesses the power of cells for new medicines across neurology, cardiology and autoimmune indications.

Register for Details

For more details on financing and valuation for BlueRock Therapeutics, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for BlueRock Therapeutics.

Register Today

Team

Management Team

Emile Nuwaysir Ph.D
Chief Executive Officer, President & Board Member
Shane Kovacs
Chief Business and Financial Officer
Robert Deans Ph.D
Chief Technology Officer
Min Wang Ph.D
Chief Administrative & Legal Officer
Joachim Fruebis Ph.D
Chief Development Officer
Gordon Keller Ph.D
Scientific Co-Founder
Lorenz Studer Ph.D
Scientific Co-Founder
Michael Scott Ph.D
Senior Vice President, Product Development

Board Members

Axel Bouchon
Bradley Bolzon Ph.D
Versant Venture Management
Jerel Davis Ph.D
Versant Venture Management
Jurg Eckardt MD

Other companies like BlueRock Therapeutics in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$1.3B
Sector
Last Round Est. Valuation
$3.1B
Sector
Last Round Est. Valuation
$5.81B
Sector
Last Round Est. Valuation
$1.2B
Sector
Last Round Est. Valuation
$1.6B
Sector
Last Round Est. Valuation
$1.61B